Details of the Drug Formulation (DFM)
General Information of DFM (ID: F23556) | |||||
---|---|---|---|---|---|
Name |
Tamoxifen Citrate eq 20mg base/10ml solution
|
||||
Company |
Mayne Pharma
|
||||
Active Pharmaceutical Ingredient (API) | Tamoxifen | API Info click to show the detail info of this API | |||
Breast cancer | ICD-11: 2C60 | Approved | |||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E03GSO | DIG Info | Anethole | Flavoring agent | ||
E0SF4Y | DIG Info | Ethanol | Antimicrobial preservative ... | ||
E06WYP | DIG Info | Glycerin | Antimicrobial preservative ... | ||
E0M1JK | DIG Info | Propylene glycol | Antimicrobial preservative ... | ||
E0G5FT | DIG Info | Sorbitan tristearate | Dispersing agent ... | ||
E0H2SC | DIG Info | Water | Solvent | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Propylene glycol | |||||
Biological Activity | Inhibition ratio < 20 % (tested by experiment) | [1] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
Hydrolase (HDase) | ||||||
DBT Name: Acetylcholinesterase (ACHE) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Anethole | |||||
Biological Activity | IC50 = 3630.78 nM (estimated based on the structural similarity with CHEMBL154155 ) | [2] | ||||
Structural Similarity | Tanimoto coefficient = 1 | |||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ACES_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.